Federica Marcoli

Dr. Federica Marcoli


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
ESElenoire Maria Sole
Elenoire Maria Sole
GMGiuseppe Motta
Giuseppe Motta
FMFederica Marcoli
Federica Marcoli
AMAngelina Midiri
Angelina Midiri
CSCinzia Sindona
Cinzia Sindona
CBCarmelo Biondo
Carmelo Biondo
Microorganisms can aggregate and organise into structured communities embedded within an exopolysaccharide-based matrsix, which serves as a protective barrier and a functional environment around microbial cells. The formation of biofilms is widely recognised as a pivotal factor in bacterial virulence, impeding the efficacy of antimicrobial agents and hindering immune responses, whilst concomitantly contributing to the development of antimicrobial resistance and the onset of persistent infections. Biofilm formation is a tightly regulated and dynamic process, controlled by quorum-sensing mechanisms and profoundly influenced by environmental factors and nutrient availability. The objective of this review is to elucidate the significance of biofilms in clinical settings, with a particular focus on their role in the pathogenesis of infectious diseases. Particular attention is devoted to biofilm-associated infections and infections related to invasive medical devices, with a particular emphasis on the most prevalent microbial pathogens, which include S. aureus, S. epidermidis, P. aeruginosa, E. coli, K. pneumoniae, A. baumannii and various species of Candida. Furthermore, the present review encompasses biofilm-associated chronic infections, conditions manifesting in predisposed patients, including individuals affected by cystic fibrosis. This review further examines the most recent strategies for combating antibiotic resistance in bacterial biofilms. This review focuses on recent biofilm pathogenesis advancements, with a focus on diagnosis challenges and the need for new ways to disrupt biofilm integrity.

9 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ESElenoire Maria Sole
Elenoire Maria Sole
GMGiuseppe Motta
Giuseppe Motta
FMFederica Marcoli
Federica Marcoli
AMAngelina Midiri
Angelina Midiri
CSCinzia Sindona
Cinzia Sindona
CBCarmelo Biondo
Carmelo Biondo
Microorganisms can aggregate and organise into structured communities embedded within an exopolysaccharide-based matrix, which serves as a protective barrier and an functional environment around microbial cells. The formation of biofilms is widely recognised as a pivotal factor in bacterial virulence, impeding the efficacy of antimicrobial agents and hindering immune responses, whilst concomitantly contributing to the development of antimicrobial resistance and the onset of persistent infections. Biofilm formation is a tightly regulated and dynamic process, controlled by quorum sensing mechanisms and profoundly influenced by enviromental factors and nutrient availability. The objective of this review is to elucidate the significance of biofilms in clinical settings, with a particular focus on their role in the pathogenesis of infectious diseases. Particular attention is devoted to biofilm-associated infections related to invasive medical devices as well as to chronic conditions occurring in predisposed patients, including individuals with cystic fibrosis. This review also examines the structure of biofilms and the bacteria responsible for their production, as well as the latest strategies for combating antibiotic resistance in bacterial biofilms. Furthermore, the role of biofilm-associated infections is analysed, with a focus on recent advancements in biofilm pathogenesis, diagnostic challenges and the necessity for innovative therapeutic strategies to disrupt biofilm integrity.